Ulrike Held

Ulrike Held

Auto-generated profile, based on publicly available information

Ulrike Held

Department of Biostatistics at the Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in SLEEP
Verified
Journal Article
Open access
PDF file
PVPhilipp O. Valko
Philipp O. Valko
CBClaudio L. Bassetti
Claudio L. Bassetti
KBKonrad E. Bloch
Konrad E. Bloch
UHUlrike Held
Ulrike Held
CBChristian R. Baumann
Christian R. Baumann
Fatigue is highly prevalent and has a negative impact on quality of life and performance in a variety of disorders. The 9-item Fatigue Severity Scale (FSS) is one of the most commonly used self-report questionnaires to measure fatigue, but has only been validated in small sample-sized studies and in single disorders. To validate the FSS in healthy subjects and different disorders known to be commonly associated with fatigue. The FSS was administered to 454 healthy subjects, 188 patients with multiple sclerosis (MS), 235 patients with recent ischemic stroke, and 429 patients with sleep-wake disorders including narcolepsy with cataplexy (n = 22), restless legs syndrome (RLS) (n = 79), sleep apnea (n = 108), insomnia (n = 62), parasomnia (n = 25), excessive daytime sleepiness/hypersomnia of other origin (n = 84), and other sleep-wake disorders (n = 49). FSS scores were 4.66 ± 1.64 (mean ± SD) in patients with MS, 3.90 ± 1.85 in patients after ischemic stroke, and 4.34 ± 1.64 in patients with sleep-wake disorders. Compared to patients, values were significantly lower in healthy subjects (3.00 ± 1.08, P < 0.01). Scores did not correlate with gender, age, or education. Item analysis showed an excellent internal consistency and reliability (Cronbach α = 0.93). Test-retest variability was assessed in 104 healthy subjects, showing stable values over time (2.94 ± 0.90 vs. 2.90 ± 0.74; P = 0.27). This first validation of a fatigue scale in a large sample size demonstrates that the FSS is a simple and reliable instrument to assess and quantify fatigue for clinical and research purposes.

1 August 2009 in The Lancet
Verified
Journal Article
Closed access
MPMilo A Puhan
Milo A Puhan
JGJudith Garcia-Aymerich
Judith Garcia-Aymerich
MFMartin Frey
Martin Frey
GRGerben ter Riet
Gerben ter Riet
JAJosep M Antó
Josep M Antó
UHUlrike Held
Ulrike Held

11 June 2008 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
MPM. A. Puhan
M. A. Puhan
MMM. J. Mador
M. J. Mador
UHU. Held
U. Held
RGR. Goldstein
R. Goldstein
GGG. H. Guyatt
G. H. Guyatt
HSH. J. Schünemann
H. J. Schünemann
There is uncertainty about the interpretation of changes in the 6-min walk distance (6MWD) in chronic obstructive pulmonary disease (COPD) patients and whether the minimal important difference (MID) for this useful outcome measure exists.Data were used from nine trials enrolling a wide spectrum of COPD patients with 6MWD at baseline and follow-up and used to determine threshold values for important changes in 6MWD using three distribution-based methods. Anchor-based methods to determine a MID were also evaluated.Data were included of 460 COPD patients with a mean±sdforced expiratory volume in one second (FEV1) of 39.2±14.1% predicted and 6MWD of 361±112 m at baseline. Threshold values for important effects in 6MWD were between 29 and 42 m, respectively, using the empirical rule effect size and the standardised response mean. The threshold value was 35 m (95% confidence interval 30–42 m) based on the standard error of measurement. Correlations of 6MWD with patient-reported anchors were too low to provide meaningful MID estimates.6-min walk distance should change by ∼35 m for patients with moderate to severe chronic obstructive pulmonary disease in order to represent an important effect. This corresponds to a 10% change of baseline 6-min walk distance. The low correlations of 6-min walk distance with patient-reported anchors question whether a minimal important difference exists for the 6-min walk distance.

1 November 2014 in The Spine Journal
Verified
Journal Article
Closed access
MWMaria M. Wertli
Maria M. Wertli
RERebekka Eugster
Rebekka Eugster
UHUlrike Held
Ulrike Held
JSJohann Steurer
Johann Steurer
RKReto Kofmehl
Reto Kofmehl
SWSherri Weiser
Sherri Weiser

1 November 2014 in The Spine Journal
Verified
Journal Article
Closed access
MWMaria M. Wertli
Maria M. Wertli
EREva Rasmussen-Barr
Eva Rasmussen-Barr
UHUlrike Held
Ulrike Held
SWSherri Weiser
Sherri Weiser
LBLucas M. Bachmann
Lucas M. Bachmann
FBFlorian Brunner
Florian Brunner

19 March 2014 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
DTDaniel Thoma
Daniel Thoma
BBBorvornwut Buranawat
Borvornwut Buranawat
CHChristoph H.F. Hämmerle
Christoph H.F. Hämmerle
UHUlrike Held
Ulrike Held
RJRonald E. Jung
Ronald E. Jung